Bio-Rad Laboratories Revenue 2010-2022 | BIO.B

Bio-Rad Laboratories annual/quarterly revenue history and growth rate from 2010 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Bio-Rad Laboratories revenue for the quarter ending September 30, 2022 was $0.681B, a 8.87% decline year-over-year.
  • Bio-Rad Laboratories revenue for the twelve months ending September 30, 2022 was $2.805B, a 5.87% decline year-over-year.
  • Bio-Rad Laboratories annual revenue for 2021 was $2.923B, a 14.81% increase from 2020.
  • Bio-Rad Laboratories annual revenue for 2020 was $2.546B, a 10.12% increase from 2019.
  • Bio-Rad Laboratories annual revenue for 2019 was $2.312B, a 0.97% increase from 2018.
Bio-Rad Laboratories Annual Revenue
(Millions of US $)
2021 $2,923
2020 $2,546
2019 $2,312
2018 $2,289
2017 $2,160
2016 $2,068
2015 $2,019
2014 $2,175
2013 $2,133
2012 $2,069
2011 $2,074
2010 $1,927
2009 $1,784
Bio-Rad Laboratories Quarterly Revenue
(Millions of US $)
2022-09-30 $681
2022-06-30 $691
2022-03-31 $700
2021-12-31 $733
2021-09-30 $747
2021-06-30 $716
2021-03-31 $727
2020-12-31 $790
2020-09-30 $647
2020-06-30 $537
2020-03-31 $572
2019-12-31 $624
2019-09-30 $561
2019-06-30 $573
2019-03-31 $554
2018-12-31 $617
2018-09-30 $545
2018-06-30 $576
2018-03-31 $552
2017-12-31 $621
2017-09-30 $534
2017-06-30 $505
2017-03-31 $500
2016-12-31 $571
2016-09-30 $509
2016-06-30 $517
2016-03-31 $471
2015-12-31 $571
2015-09-30 $470
2015-06-30 $506
2015-03-31 $473
2014-12-31 $598
2014-09-30 $531
2014-06-30 $537
2014-03-31 $509
2013-12-31 $603
2013-09-30 $505
2013-06-30 $525
2013-03-31 $500
2012-12-31 $574
2012-09-30 $499
2012-06-30 $510
2012-03-31 $486
2011-12-31 $550
2011-09-30 $517
2011-06-30 $522
2011-03-31 $485
2010-12-31 $534
2010-09-30 $472
2010-06-30 $468
2010-03-31 $454
2009-12-31 $495
2009-09-30 $461
2009-06-30 $427
2009-03-31 $401
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.069B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $171.581B 10.47
GSK (GSK) United Kingdom $71.504B 8.96
QIAGEN (QGEN) Netherlands $11.167B 19.06
Ginkgo Bioworks Holdings (DNA) United States $3.492B 0.00
Myovant Sciences (MYOV) United Kingdom $2.595B 0.00
Arcus Biosciences (RCUS) United States $2.459B 36.91
Biohaven (BHVN) United States $1.112B 0.00
Emergent Biosolutions (EBS) United States $0.588B 4.62
Zymeworks (ZYME) Canada $0.480B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.270B 0.00
Enzo Biochem (ENZ) United States $0.092B 0.00
SQZ Biotechnologies (SQZ) United States $0.042B 0.00
Gelesis Holdings (GLS) United States $0.032B 0.00
Ambrx Biopharma (AMAM) United States $0.020B 0.00